These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Four patients with a new lysosomal storage disorder (Salla disease). Aula P; Raivio K; Autio S; Thoden CE; Rapola J; Koskela SL; Yamashina I Monogr Hum Genet; 1978; 10():16-22. PubMed ID: 723890 [No Abstract] [Full Text] [Related]
3. Salla disease variants. Sialoylaciduric encephalopathy with increased sialidase activity in two non-Finnish children. Ylitalo V; Hagberg B; Rapola J; Månsson JE; Svennerholm L; Sanner G; Tonnby B Neuropediatrics; 1986 Feb; 17(1):44-7. PubMed ID: 3960283 [TBL] [Abstract][Full Text] [Related]
4. Finnish type of sialic acid storage disease with sialuria (Salla disease): the occurrence and diagnostic significance of cytoplasmic vacuoles in blood lymphocytes. Similä S; Linna SL; Väyrynen M; Autio-Harmainen H; von Wendt L; Ruokonen A J Ment Defic Res; 1985 Jun; 29 ( Pt 2)():179-86. PubMed ID: 4032465 [TBL] [Abstract][Full Text] [Related]
5. The spectrum of free neuraminic acid storage disease in childhood: clinical, morphological and biochemical observations in three non-Finnish patients. Sewell AC; Poets CF; Degen I; Stöss H; Pontz BF Am J Med Genet; 1996 May; 63(1):203-8. PubMed ID: 8723111 [TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory diagnosis of Salla disease in infancy and childhood. Renlund M J Pediatr; 1984 Feb; 104(2):232-6. PubMed ID: 6694015 [TBL] [Abstract][Full Text] [Related]
7. Imipramine induced lipidosis and dexamethasone effect: morphological and biochemical study in normal and chronic GM2 gangliosidosis fibroblasts. Palmeri S; Mangano L; Battisti C; Malandrini A; Federico A J Neurol Sci; 1992 Jul; 110(1-2):215-21. PubMed ID: 1506862 [TBL] [Abstract][Full Text] [Related]
8. Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism. Renlund M; Aula P; Raivio KO; Autio S; Sainio K; Rapola J; Koskela SL Neurology; 1983 Jan; 33(1):57-66. PubMed ID: 6681560 [TBL] [Abstract][Full Text] [Related]
9. [Detection of vacuolated peripheral blood lymphocytes in screening for and diagnosis of lysosomal storage diseases]. Chang XZ; Liu JY; Wu Y; Jiang YW; Xiong H; Wang S; Qin J Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):135-8. PubMed ID: 21426694 [TBL] [Abstract][Full Text] [Related]
10. Normalization of intracellular lysosomal hydrolases in I-cell disease fibroblasts with sucrose loading. Kato T; Okada S; Ohshima T; Inui K; Yutaka T; Yabuuchi H J Biol Chem; 1982 Jul; 257(13):7814-9. PubMed ID: 7085649 [TBL] [Abstract][Full Text] [Related]
11. An Italian severe Salla disease variant associated with a SLC17A5 mutation earlier described in infantile sialic acid storage disease. Biancheri R; Verbeek E; Rossi A; Gaggero R; Roccatagliata L; Gatti R; van Diggelen O; Verheijen FW; Mancini GM Clin Genet; 2002 Jun; 61(6):443-7. PubMed ID: 12121352 [TBL] [Abstract][Full Text] [Related]
12. Marinesco-Sjögren syndrome: evidence for a lysosomal storage disorder. Walker PD; Blitzer MG; Shapira E Neurology; 1985 Mar; 35(3):415-9. PubMed ID: 3974903 [TBL] [Abstract][Full Text] [Related]
13. Culture conditions found to minimize false positive diagnosis of lysosomal storage disorders. Arnon J; Ornoy A; Bach G In Vitro Cell Dev Biol; 1988 Dec; 24(12):1159-64. PubMed ID: 3209585 [TBL] [Abstract][Full Text] [Related]
14. Ultrastructure of skin biopsy specimens in lysosomal storage diseases: common sources of error in diagnosis. Sipe JC; O'Brien JS Clin Genet; 1979 Feb; 15(2):118-25. PubMed ID: 761412 [TBL] [Abstract][Full Text] [Related]
15. [Salla disease (sialuria, Finnish type). New clinical presentation in the 1st Argentine report]. Dodelson de Kremer R; Depetris de Boldini C; Paschini de Capra A; Hliba E Medicina (B Aires); 1990; 50(2):107-16. PubMed ID: 2101844 [TBL] [Abstract][Full Text] [Related]
16. Infantile type of sialic acid storage disease with sialuria. Paschke E; Trinkl G; Erwa W; Pavelka M; Mutz I; Roscher A Clin Genet; 1986 May; 29(5):417-24. PubMed ID: 3742847 [TBL] [Abstract][Full Text] [Related]
17. Studies on the defect underlying the lysosomal storage of sialic acid in Salla disease. Lysosomal accumulation of sialic acid formed from N-acetyl-mannosamine or derived from low density lipoprotein in cultured mutant fibroblasts. Renlund M; Kovanen PT; Raivio KO; Aula P; Gahmberg CG; Ehnholm C J Clin Invest; 1986 Feb; 77(2):568-74. PubMed ID: 3944269 [TBL] [Abstract][Full Text] [Related]
18. Ichthyosis, mental retardation, and asymptomatic spasticity. A new neurocutaneous syndrome with normal fatty alcohol:NAD+ oxidoreductase activity. Koone MD; Rizzo WB; Elias PM; Williams ML; Lightner V; Pinnell SR Arch Dermatol; 1990 Nov; 126(11):1485-90. PubMed ID: 2241202 [TBL] [Abstract][Full Text] [Related]
19. Neuraminidase deficiency in the original patient with the Goldberg syndrome. Thomas GH; Goldberg MF; Miller CS; Reynolds LW Clin Genet; 1979 Nov; 16(5):323-30. PubMed ID: 519904 [TBL] [Abstract][Full Text] [Related]
20. Clinical, biochemical, and molecular diagnosis of a free sialic acid storage disease patient of moderate severity. Kleta R; Morse RP; Orvisky E; Krasnewich D; Alroy J; Ucci AA; Bernardini I; Wenger DA; Gahl WA Mol Genet Metab; 2004 Jun; 82(2):137-43. PubMed ID: 15172001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]